Beta Drugs Share Price
₹1,993.70 +110.05 (5.84%)
02 Feb, 2025 10:37
Start SIP in BETA
Start SIPPerformance
- Low
- ₹1,900
- High
- ₹2,000
- 52 Week Low
- ₹1,060
- 52 Week High
- ₹2,326
- Open Price₹1,920
- Previous Close₹1,884
- Volume7,500
Investment Returns
- Over 1 Month + 0.52%
- Over 3 Month + 1.14%
- Over 6 Month + 55.87%
- Over 1 Year + 38.93%
Smart Investing Starts Here Start SIP with Beta Drugs for Steady Growth!
Beta Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 52.6
- PEG Ratio
- -
- Market Cap Cr
- 1,917
- P/B Ratio
- 10.6
- Average True Range
- 99.12
- EPS
- 37.9
- Dividend Yield
- 0
- MACD Signal
- -45.37
- RSI
- 53.46
- MFI
- 47.61
Beta Drugs Financials
Beta Drugs Technicals
EMA & SMA
Current Price
₹1,993.70
+
110.05
(5.84%)
- Bullish Moving Average 15
- Bearish Moving Average 1
- 20 Day
- ₹1,918.02
- 50 Day
- ₹1,954.67
- 100 Day
- ₹1,886.49
- 200 Day
- ₹1,707.95
Resistance and Support
1964.57
- R3 2,129.13
- R2 2,064.57
- R1 2,029.13
- S1 1,929.13
- S2 1,864.57
- S3 1,829.13
Beta Drugs Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-06 | Quarterly Results | |
2024-10-19 | To consider Fund Raising | |
2024-05-14 | Audited Results | |
2023-11-07 | Quarterly Results & Others | To consider the Migration of the Equity shares of the Company from Emerge-SME Platform of National Stock Exchange of India Limited ( NSE Emerge ) to the Main board of NSE and BSE. |
2023-05-08 | Audited Results |
Beta Drugs F&O
About Beta Drugs
- NSE Symbol
- BETA
- BSE Symbol
- 531481
- Chairperson & Managing Director
- Mr. Rahul Batra
- ISIN
- INE351Y01019
Similar Stocks to Beta Drugs
Beta Drugs FAQs
Beta Drugs share price is ₹1,993 As on 02 February, 2025 | 10:23
The Market Cap of Beta Drugs is ₹1916.7 Cr As on 02 February, 2025 | 10:23
The P/E ratio of Beta Drugs is 52.6 As on 02 February, 2025 | 10:23
The PB ratio of Beta Drugs is 10.6 As on 02 February, 2025 | 10:23
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.